NASDAQ · Medical - Healthcare Information Services

10x Genomics, Inc. (TXG) Stock

$80.65 +4.36% NASDAQ: TXG Healthcare

Valuation

MetricValue
Price$80.65
Market Cap$10.24B
P/E Ratio-158.47
P/B Ratio14.72
P/S Ratio19.24
EPS (TTM)$-0.35
52-Week High$97.74
52-Week Low$11.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.33%
ROA-7.29%
ROCE-9.70%
Gross Margin-17.26%
Operating Margin-17.26%
Net Margin-12.18%
Debt/Equity0.10
Current Ratio4.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$490.0M$516.0M$619.0M$611.0M$643.0M
Operating Profit$-53.0M$-168.0M$-265.0M$-195.0M$-111.0M
Net Profit$-58.0M$-166.0M$-255.0M$-183.0M$-44.0M
EPS$-0.53$-1.46$-2.18$-1.52$-0.35
Op Margin-10.8%-32.5%-42.9%-31.9%-17.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0B$1.0B$965.0M$919.0M$1.0B
Total Liabilities$201.0M$223.0M$224.0M$209.0M$245.0M
Cash$587.0M$220.0M$359.0M$344.0M$474.0M
Borrowings$82.0M$95.0M$95.0M$83.0M$158.0M

Latest News

Cathie Wood Dumps $39 Million Worth of AMD Stock GuruFocus.com · Jul 20, 2026 1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges StockStory · Jul 20, 2026 3 Russell 2000 Stocks We Steer Clear Of StockStory · Jul 16, 2026 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire · Jul 15, 2026 Cathie Wood’s ARK Invest Doubles Down On Circle In Two Funds At Once, Trims Robinhood Again Stocktwits · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-34.0M$-15.0M$7.0M$136.0M
Investing Cash Flow$-208.0M$-483.0M$84.0M$-45.0M$-19.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-93.0M$-369.0M$132.0M$-15.0M$130.0M
Free Cash Flow$-123.0M$-165.0M$-65.0M$-6.0M$130.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.35
EV / EBITDA408.75
FCF Yield1.02%
Quick Ratio5.25
Interest Coverage-29461.33
Return 1Y538.13%
Return 3Y108.59%
Return 5Y-47.63%

Ownership

Insiders Held1.67%
Institutions Held112.04%
Institutions Float Held113.94%
Institutional HolderSharesReport Date
FMR, LLC17,740,9722026-03-31
ARK Investment Management, LLC11,717,3172026-03-31
Blackrock Inc.10,079,9132026-03-31
Vanguard Portfolio Management LLC6,912,9362026-03-31
Quantinno Capital Management, LP5,411,7612026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $170.54 +1.41% 33.95 $48.17B 0.59%
BIOBio-Rad Laboratories, Inc. $366.16 +1.60% 44.31 $9.86B 0.00%
GNNSFGenscript Biotech Corporation $3.08 +5.12% -12.23 $6.73B 0.00%
ILMNIllumina, Inc. $278.17 +5.14% 49.91 $42.09B 0.00%
LABStandard BioTools Inc. $0.69 +2.85% -3.23 $269.87M 0.00%

About 10x Genomics, Inc.

10x Genomics, Inc. (TXG) stock trades at $80.65 with a market capitalization of $10.24B. The stock is valued at a price-to-earnings (P/E) ratio of -158.47, price-to-book of 14.72, price-to-sales of 19.24. Over the past 52 weeks the stock has ranged between $11.16 and $97.74, and currently trades 17.5% below its 52-week high.

On profitability, 10x Genomics, Inc. generates a return on equity (ROE) of -9.33%, return on capital employed of -9.70%, an operating margin of -17.26%, a net profit margin of -12.18%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides